Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie Allen

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Pathology|November 30, 2021
Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variantsAlberto Valenzuela-Palomo, Elena Bueno-Martínez, Lara Sanoguera-Miralles, et al.
International Journal of Cancer|September 4, 2018
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohortJingmei Li, Wei Xiong Wen, Martin Eklund, et al.
Neurology. Genetics|September 3, 2025
Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular DystrophyChad Rydel Heatwole, Elizabeth Luebbe, Johanna Hamel, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
NPJ Breast Cancer|May 13, 2021
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjectsNa Li, Magnus Zethoven, Simone McInerny, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic MutationsThomas U Ahearn, Parichoy Pal Choudhury, Andriy Derkach, et al.
Nucleic Acids Research|November 7, 2019
Ensembl 2020Andrew D Yates, Premanand Achuthan, Wasiu Akanni, et al.
Nucleic Acids Research|November 2, 2020
Ensembl 2021Kevin L Howe, Premanand Achuthan, James Allen, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Pathology|November 30, 2021
Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variantsAlberto Valenzuela-Palomo, Elena Bueno-Martínez, Lara Sanoguera-Miralles, et al.
International Journal of Cancer|September 4, 2018
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohortJingmei Li, Wei Xiong Wen, Martin Eklund, et al.
Neurology. Genetics|September 3, 2025
Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular DystrophyChad Rydel Heatwole, Elizabeth Luebbe, Johanna Hamel, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
The Lancet Regional Health. Western Pacific|February 9, 2024
Age-specific breast and ovarian cancer risks associated with germline <i>BRCA1</i> or <i>BRCA2</i> pathogenic variants - an Asian study of 572 familiesWeang-Kee Ho, Nur Tiara Hassan, Sook-Yee Yoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2022
Predicting the Likelihood of Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation in Asian Patients With Breast CancerBoon Hong Ang, Weang Kee Ho, Eldarina Wijaya, et al.
NPJ Breast Cancer|May 13, 2021
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjectsNa Li, Magnus Zethoven, Simone McInerny, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic MutationsThomas U Ahearn, Parichoy Pal Choudhury, Andriy Derkach, et al.
Nucleic Acids Research|November 7, 2019
Ensembl 2020Andrew D Yates, Premanand Achuthan, Wasiu Akanni, et al.
Nucleic Acids Research|November 2, 2020
Ensembl 2021Kevin L Howe, Premanand Achuthan, James Allen, et al.
Pageof 5